Fidelity Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Fidelity Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.84B	Buy	24,556,637 +484,536	+2%	+$38.2M	0.1%	174
2025 Q4	$1.9B	Buy	24,072,101 +383,063	+2%	+$28.8M	0.1%	161
2025 Q3	$1.55B	Buy	23,689,038 +46,048	+0.2%	+$2.25M	0.08%	189
2025 Q2	$934M	Buy	23,642,990 +29,405	+0.1%	+$962K	0.05%	293
2025 Q1	$712M	Buy	23,613,585 +924,094	+4%	+$30.3M	0.05%	332
2024 Q4	$793M	Buy	22,689,491 +209,962	+0.9%	+$7.85M	0.05%	320
2024 Q3	$901M	Buy	22,479,529 +584,723	+3%	+$27.2M	0.05%	296
2024 Q2	$1.04B	Buy	21,894,806 +32,071	+0.1%	+$1.32M	0.07%	240
2024 Q1	$948M	Buy	21,862,735 +341,863	+2%	+$16.3M	0.06%	274
2023 Q4	$1.09B	Buy	21,520,872 +21,950	+0.1%	+$1.05M	0.08%	210
2023 Q3	$975M	Buy	21,498,922 +35,106	+0.2%	+$1.45M	0.08%	207
2023 Q2	$881M	Buy	21,463,816 +27,482	+0.1%	+$1.06M	0.07%	237
2023 Q1	$766M	Buy	21,436,334 +128,815	+0.6%	+$4.84M	0.07%	287
2022 Q4	$805M	Buy	21,307,519 +16,360	+0.1%	+$688K	0.08%	244
2022 Q3	$942M	Buy	21,291,159 +21,599	+0.1%	+$910K	0.1%	183
2022 Q2	$787M	Sell	21,269,560 -51,326	-0.2%	-$1.94M	0.08%	236
2022 Q1	$790M	Buy	21,320,886 +139,384	+0.7%	+$4.56M	0.06%	299
2021 Q4	$645M	Buy	21,181,502 +9,348	+0%	+$294K	0.05%	365
2021 Q3	$710M	Buy	21,172,154 +27,699	+0.1%	+$1.04M	0.06%	316
2021 Q2	$843M	Buy	21,144,455 +50,559	+0.2%	+$1.98M	0.07%	269
2021 Q1	$948M	Buy	21,093,896 +155,862	+0.7%	+$8.69M	0.08%	229
2020 Q4	$1.18B	Buy	20,938,034 +71,082	+0.3%	+$3.54M	0.11%	179
2020 Q3	$990M	Buy	20,866,952 +56,398	+0.3%	+$3.13M	0.1%	184
2020 Q2	$1.23B	Sell	20,810,554 -149,673	-0.7%	-$8.33M	0.13%	134
2020 Q1	$991M	Hold	20,960,227	–	–	0.14%	140
2019 Q4	$1.27B	Buy	20,960,227 +24,443	+0.1%	+$1.46M	0.14%	140
2019 Q3	$1.25B	Buy	20,935,784 +26,522	+0.1%	+$1.73M	0.15%	133
2019 Q2	$1.34B	Buy	20,909,262 +275,564	+1%	+$19.5M	0.16%	120
2019 Q1	$1.67B	Buy	20,633,698 +123,948	+0.6%	+$8M	0.2%	91
2018 Q4	$1.11B	Buy	20,509,750 +45,911	+0.2%	+$2.34M	0.15%	126
2018 Q3	$1.06B	Buy	20,463,839 +1,635,782	+9%	+$76.9M	0.12%	157
2018 Q2	$785M	Buy	18,828,057 +17,575	+0.1%	+$779K	0.09%	209
2018 Q1	$829M	Buy	18,810,482 +91,157	+0.5%	+$4.63M	0.1%	204
2017 Q4	$942M	Buy	18,719,325 +66,122	+0.4%	+$3.63M	0.11%	193
2017 Q3	$946M	Buy	18,653,203 +58,369	+0.3%	+$3.06M	0.11%	183
2017 Q2	$946M	Buy	18,594,834 +32,414	+0.2%	+$1.51M	0.12%	190
2017 Q1	$746M	Buy	18,562,420 +381,975	+2%	+$17.2M	0.09%	223
2016 Q4	$870M	Buy	18,180,445 +42,591	+0.2%	+$1.69M	0.12%	185
2016 Q3	$665M	Buy	18,137,854 +20,406	+0.1%	+$638K	0.09%	243
2016 Q2	$422M	Buy	18,117,448 +325,351	+2%	+$10.5M	0.06%	360
2016 Q1	$721M	Buy	17,792,097 +81,140	+0.5%	+$3.3M	0.1%	210
2015 Q4	$1.1B	Buy	17,710,957 +23,310	+0.1%	+$1.26M	0.15%	143
2015 Q3	$715M	Buy	17,687,647 +37,345	+0.2%	+$1.93M	0.1%	206
2015 Q2	$1.02B	Buy	17,650,302 +104,252	+0.6%	+$6.63M	0.13%	166
2015 Q1	$1.12B	Buy	17,546,050 +14,317	+0.1%	+$971K	0.14%	152
2014 Q4	$1.08B	Sell	17,531,733 -18,000	-0.1%	-$888K	0.14%	154
2014 Q3	$681M	Hold	17,549,733	–	–	0.09%	245
2014 Q2	$605M	Hold	17,549,733	–	–	0.08%	283
2014 Q1	$758M	Buy	17,549,733 +592,014	+3%	+$28.7M	0.11%	203
2013 Q4	$676M	Sell	16,957,719 -30,000	-0.2%	-$1.07M	0.1%	233
2013 Q3	$638M	Buy	16,987,719 +765,455	+5%	+$22.9M	0.1%	241
2013 Q2	$436M	Buy	+16,222,264	New	+$345M	0.07%	317